A KRAS Wild Type Mutational Status Confers a Survival Advantage in Pancreatic Ductal Adenocarcinoma

Journal of Gastrointestinal Oncology - Hong Kong
doi 10.21037/jgo.2017.10.14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AME Publishing Company

Related search

Long-Term Survival in Locally Advanced KRAS Wild-Type Pancreatic Adenocarcinoma

Case Reports in Gastrointestinal Medicine
2019English

The Impact of a History of Cancer on Pancreatic Ductal Adenocarcinoma Survival

United European Gastroenterology Journal
OncologyGastroenterology
2018English

A Single Nucleotide Polymorphism in the CD44 Gene Affects Survival of Pancreatic Ductal Adenocarcinoma

HPB
HepatologyGastroenterology
2016English

Nationwide Trends in Incidence, Treatment and Survival of Pancreatic Ductal Adenocarcinoma

European Journal of Cancer
Cancer ResearchOncology
2020English

A PD-L2-based Immune Marker Signature Helps to Predict Survival in Resected Pancreatic Ductal Adenocarcinoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Non-Coding RNAs in Pancreatic Ductal Adenocarcinoma

Frontiers in Oncology
Cancer ResearchOncology
2020English

Pancreatic Ductal Adenocarcinoma With Cystic Features

HPB
HepatologyGastroenterology
2016English

Tumor-Stroma Interactions in Pancreatic Ductal Adenocarcinoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2007English

Predictors for Survival in Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma (DIPLOMA): A Pan-European Cohort

HPB
HepatologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy